Engineered Bifunctional Proteins for Targeted Cancer Therapy: Prospects and Challenges

Area of Science:

• Biotechnology
• Molecular Biology
• Oncology

Background:

• Bifunctional proteins (BFPs) are engineered therapeutics with multiple biological functions.
• They offer improved efficacy and reduced toxicity compared to conventional drugs.
• BFPs are particularly promising for treating heterogeneous tumors.

Purpose of the Study:

• To review the structural features and classification of BFPs.
• To discuss recent advancements in BFP development.
• To outline challenges and future directions for clinical applications.

Main Methods:

• Classification of BFPs based on their mode of action: bispecific antibodies, immunocytokines, and immunotoxins.
• Review of current literature on BFP development and clinical studies.
• Analysis of structural characteristics and therapeutic benefits.

Main Results:

• BFPs exhibit potent biological activity by targeting multiple pathways or mediating immune responses.
• Categorization into bispecific antibodies, immunocytokines, and immunotoxins provides a framework for understanding their diverse mechanisms.
• BFPs demonstrate potential for overcoming limitations of single-target therapies.

Conclusions:

• BFPs represent a promising class of therapeutics for cancer treatment.
• Further research into BFP characteristics is crucial for optimizing drug design and enhancing clinical efficacy.
• Addressing limitations in clinical application will be key to realizing the full potential of BFPs.